News tagged ‘PatientEducation’ clear
- Treatment with three "targeted" cancer drugs has been linked to a slightly elevated chance of fatal side effects, according to a new analysis led by scientists at Dana-Farber. These risks remain low, but they should be factored in when developing patients’ treatment plans.
Tags: chemotherapy, PatientEducation, PatientSafety, TargetedTherapy
- Compared to adult patients, parents felt they had little time to
understand the clinical trials process in the midst of coming to terms
with their child's cancer diagnosis.
Tags: ChildhoodCancer, PatientEducation
- Dana-Farber is expanding its digital publishing efforts with the launch of Paths of Progress, the Institute's twice-yearly research and care magazine, as an iPad application enhanced with animations and web links.
- A study led by Jennifer Mack, MD, MPH, suggests that many terminally ill cancer patients do talk with a doctor about their preferences for end-of-life care, but those conversations often occur late in the course of their illness and tend to be with a hospital-based physician and not their oncologist who has been caring for them.
Tags: EndOfLife, PatientEducation, PatientSupport
- A new study finds many breast cancer patients don't know the characteristics of their own disease, such as cancer stage and tumor grade.
Tags: BreastCancer, PatientEducation
- Many favorite winter holiday foods, including pumpkin, cranberries and apples, are also packed with cancer-fighting nutrients, say nutritionists at Dana-Farber Cancer Institute.
- Paths of Progress, Dana-Farber’s award-winning cancer research magazine, is now available as a free app for iPad, Android and Kindle Fire tablets.